Pre-eclampsia Risk Screening (NICE NG133)
NICE NG133 pre-eclampsia risk factors: any high-risk factor, or more than one moderate-risk factor, indicates aspirin from 12 weeks.
Score interpretation
No NICE NG133 risk factors for pre-eclampsia.
→ Routine antenatal care.
One moderate-risk factor only: aspirin is not indicated on NICE criteria.
→ Routine antenatal care; reassess if new risk factors appear.
Any high-risk factor, or more than one moderate-risk factor (NICE NG133).
→ Adults: advise aspirin 75–150 mg daily from 12 weeks until the birth. Children: use a children's formulary. Monitor blood pressure and urine.
Interpretation bands for the Pre-eclampsia Risk. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Magnesium Sulphate (Obstetric — Eclampsia/Neuroprotection) · Anticonvulsant / Neuroprotectant
- Hydralazine (IV — Acute Hypertension in Pregnancy) · Vasodilator (Antihypertensive)
- Methyldopa (Chronic Hypertension in Pregnancy) · Centrally Acting Antihypertensive
- Aspirin (Low-Dose — Pre-eclampsia Prevention) · Antiplatelet — Pre-eclampsia Prophylaxis
- Cefalexin (UTI / GBS Prophylaxis in Pregnancy) · First-Generation Cephalosporin — Obstetric Antibiotic
- Nitrofurantoin (UTI in Pregnancy) · Urinary Antibiotic — Obstetric
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.